{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:21:44Z","timestamp":1791897704828,"version":"4.3.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":4296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1093\/bja\/ael003","type":"journal-article","created":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T01:24:08Z","timestamp":1137461048000},"page":"377-380","source":"Crossref","is-referenced-by-count":115,"title":["Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study"],"prefix":"10.1016","volume":"96","author":[{"given":"A","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Dhiraaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/ael003_bib1","first-page":"253","article-title":"The pharmacology of lower urinary tract smooth muscles and penile erectile tissues","volume":"45","author":"Andersson","year":"1993","journal-title":"Pharmacol Rev"},{"key":"10.1093\/bja\/ael003_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1469-445X.1999.tb00083.x","article-title":"Advances in the pharmacological control of the bladder","volume":"84","author":"Andersson","year":"1999","journal-title":"Exp Physiol"},{"key":"10.1093\/bja\/ael003_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0025-6196(11)62382-3","article-title":"Prospective randomized controlled trial of extended release oxybutynin chloride and tolterodine in the treatment of overactive bladder: results of the OBJECT study","volume":"76","author":"Appell","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1093\/bja\/ael003_bib4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1213\/01.ane.0000167775.46192.e9","article-title":"The efficacy of tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double blind study","volume":"101","author":"Agarwal","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/ael003_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0094-0143(21)00501-2","article-title":"Anatomy and physiology of the lower urinary tract","volume":"20","author":"de Groat","year":"1993","journal-title":"Urol Clin North Am"},{"key":"10.1093\/bja\/ael003_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-5347(17)60721-3","article-title":"Oxybutynin: a new drug with analgesic and anticholinergic properties","volume":"108","author":"Diokno","year":"1972","journal-title":"J Urol"},{"key":"10.1093\/bja\/ael003_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yanker","year":"1995","journal-title":"Drugs Aging"},{"key":"10.1093\/bja\/ael003_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002512-200118040-00005","article-title":"Tolterodine: a review of its use in the treatment of overactive bladder","volume":"18","author":"Clmett","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1093\/bja\/ael003_bib9","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0090-4295(98)00629-3","article-title":"Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data","volume":"53","author":"Larsson","year":"1999","journal-title":"Urology"},{"key":"10.1093\/bja\/ael003_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","article-title":"Tolterodine a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder","volume":"81","author":"Abrams","year":"1998","journal-title":"Br J Urol"},{"key":"10.1093\/bja\/ael003_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s001929970003","article-title":"Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with obstructive bladder","volume":"10","author":"Drutz","year":"1999","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1093\/bja\/ael003_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0090-4295(97)00599-2","article-title":"Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis","volume":"50","author":"Appell","year":"1997","journal-title":"Urology"},{"key":"10.1093\/bja\/ael003_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.12968\/bjcn.2004.9.7.13294","article-title":"Fundamental principles of indwelling urinary catheter selection","volume":"9","author":"Robinson","year":"2004","journal-title":"Br J Community Nurs"},{"key":"10.1093\/bja\/ael003_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(97)89661-6","article-title":"Tolterodine\u2014a new bladder selective antimuscarinic agent","volume":"327","author":"Nilvebrant","year":"1997","journal-title":"Eur J Pharmacol"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709121735211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709121735211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/96\/3\/377\/929663\/ael003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:03:44Z","timestamp":1635206624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000709121735211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S000709121735211X"],"URL":"https:\/\/doi.org\/10.1093\/bja\/ael003","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}